Asie · Actualité générale · Global Times
China approves first oral GLP-1 weight-loss drug
Résumé détaillé
China on Thursday approved Eli Lilly's orforglipron pills, marketed domestically under the brand name "Muyouda," for long-term weight management in adults, making it the country's…
A Chinese man who weighed 359.4 kilograms, a national record for obesity, has successfully lost 150 kilograms through ...
Weight management has sparked a lot of interest in China as Healthy China 2030 and the promotion of ...
The population of obese people in China is increasing, with over 50 percent of adults being overweight or ...
Début de l'article, extrait de Global Times. Pour lire la suite, ouvrez l'article chez le média.
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.globaltimes.cn)
